SLC30A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.971200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.301600E-01
Normal-vs-Stage2
3.625600E-01
Normal-vs-Stage3
9.087600E-01
Normal-vs-Stage4
9.502100E-02
Stage1-vs-Stage2
8.457800E-01
Stage1-vs-Stage3
2.951600E-01
Stage1-vs-Stage4
7.462000E-02
Stage2-vs-Stage3
3.430800E-01
Stage2-vs-Stage4
3.918300E-02
Stage3-vs-Stage4
5.392200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.321000E-01
Normal-vs-AfricanAmerican
9.252000E-02
Normal-vs-Asian
4.818400E-01
Caucasian-vs-AfricanAmerican
1.672970E-01
Caucasian-vs-Asian
8.454800E-01
AfricanAmerican-vs-Asian
1.581170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.934800E-01
Normal-vs-Female
4.017000E-01
Male-vs-Female
3.765800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.700600E-01
Normal-vs-Age(41-60Yrs)
2.802000E-01
Normal-vs-Age(61-80Yrs)
4.609600E-01
Normal-vs-Age(81-100Yrs)
6.279600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.595200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.574600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.150000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.110780E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.022600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.467200E-01
Normal-vs-Daily Drinker
7.550800E-01
Normal-vs-Weekly Drinker
5.468000E-01
Normal-vs-Occasional Drinker
2.026600E-01
Normal-vs-Social Drinker
5.175200E-01
Non Drinker-vs-Daily Drinker
5.103800E-01
Non Drinker-vs-Weekly Drinker
7.861600E-01
Non Drinker-vs-Occasional Drinker
4.894100E-02
Non Drinker-vs-Social Drinker
6.546400E-01
Daily Drinker-vs-Weekly Drinker
4.871200E-01
Daily Drinker-vs-Occasional Drinker
2.196500E-02
Daily Drinker-vs-Social Drinker
3.908400E-01
Weekly Drinker-vs-Occasional Drinker
1.787450E-01
Weekly Drinker-vs-Social Drinker
8.837400E-01
Occasional Drinker-vs-Social Drinker
2.326600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.202410E-01
Normal-vs-Grade 2
3.717600E-02
Normal-vs-Grade 3
2.270400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.459580E-02
Grade 1-vs-Grade 3
1.961310E-03
Grade 1-vs-Grade 4
1.202410E-01
Grade 2-vs-Grade 3
2.258000E-01
Grade 2-vs-Grade 4
3.717600E-02
Grade 3-vs-Grade 4
2.270400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.685200E-01
Normal-vs-NonDiabetic
4.649800E-01
Diabetic-vs-NonDiabetic
7.113600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.369800E-01
Normal-vs-NoPancreatitis
4.342600E-01
Pancreatitis-vs-NoPancreatitis
9.812400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.257400E-01
Normal-vs-N1
3.789200E-01
N0-vs-N1
8.040200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.369430E-01
Normal-vs-TP53-NonMutant
3.911800E-01
TP53-Mutant-vs-TP53-NonMutant
2.900000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
